Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 80/g
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
  • Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide
Find Similar Products

Basic Info.

Certification
GMP, ISO 9001, USP, BP
Suitable for
Adult
State
Powder
Purity
>98%
Sample
Available
OEM
Available
MOQ
1kg
Keyword 1
Pomalidomide
Keyword 2
Pomalidomide Powder
Storage
Dry and Cool Place
Transport Package
Foil Bag/25kg Drum
Specification
98%
Trademark
/
Origin
China
Production Capacity
10000

Product Description

Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide

Description
Pomalidomide is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis

Name Pomalidomide
Grade Pharmaceutical Grade
Appearance yellow powder
Specification 98%


Function and Application
Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy

Pomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API PomalidomidePomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API PomalidomidePomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API PomalidomidePomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API PomalidomidePomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API PomalidomidePomalidomide Powder 99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier